Complete response (CR) rate From baseline to up to 4 years [clinicaltrials_resource:b2100dfa26882086f64fcba9a745a014]
The analysis of response will be based on a one-sided, two-sample test of proportions, with Type I error of 10%. Tumor response criteria are determined by changes in size using all 3 dimensional measurements: width (W), transverse (T), and length (L) measurements.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Complete response (CR) rate From baseline to up to 4 years [clinicaltrials_resource:b2100dfa26882086f64fcba9a745a014]
The analysis of response will be based on a one-sided, two-sample test of proportions, with Type I error of 10%. Tumor response criteria are determined by changes in size using all 3 dimensional measurements: width (W), transverse (T), and length (L) measurements.
Bio2RDF identifier
b2100dfa26882086f64fcba9a745a014
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b2100dfa26882086f64fcba9a745a014
measure [clinicaltrials_vocabulary:measure]
Complete response (CR) rate
time frame [clinicaltrials_vocabulary:time-frame]
From baseline to up to 4 years
description
The analysis of response will ...... , and length (L) measurements.
identifier
clinicaltrials_resource:b2100dfa26882086f64fcba9a745a014
title
Complete response (CR) rate From baseline to up to 4 years
@en
type
label
Complete response (CR) rate Fr ...... 00dfa26882086f64fcba9a745a014]
@en